• 제목/요약/키워드: Disease diagnosis and treatment

검색결과 2,034건 처리시간 0.03초

Varicose Veins and the Diagnosis of Chronic Venous Disease in the Lower Extremities

  • Jae Ho Chung;Seonyeong Heo
    • Journal of Chest Surgery
    • /
    • 제57권2호
    • /
    • pp.109-119
    • /
    • 2024
  • Varicose veins usually present in the superficial veins of the lower extremities and are one of the main clinical presentations of chronic venous disease (CVD). Patients' symptoms may vary according to the pathophysiology, location, and severity of CVD. The prevalence of CVD in Korea has been increasing gradually. However, due to its broad clinical spectrum and the subjective nature of its diagnosis using ultrasound, discrepancies in diagnostic and treatment quality may exist among treating physicians. There have been recent efforts to improve the quality of the diagnosis and treatment of varicose veins in Korea by standardizing the diagnostic criteria and the indications for treatment. This study is a comprehensive review of the clinical manifestations and diagnostic criteria of CVD based on the most recent international and domestic guidelines and reports.

열성 이영양성 수포성 표피박리증 환자 1례 보고 (A Case Study on Recessive Dystrophic Epidermolysis Bullosa-mitis (RDEB-mitis))

  • 권강
    • 한방안이비인후피부과학회지
    • /
    • 제20권1호통권32호
    • /
    • pp.265-284
    • /
    • 2007
  • Introduction : There are three major forms of Epidermolysis Bullosa(EB) - EB Simplex(EBS), Junctional EB(JEB) and Dystrophic EB(DEB). DEB is divided into two groups that Dominant DEB(DDEB) and Recessive DEB(RDEB). RDEB has two types that Hallopeau-Siemens(generalized type) and mitis(localized type). Objects : This study was carried out to observe the progress of Recessive Dystrophic Epidermolysis Bullosa-mitis(RDEB-mitis) disease and find effective remedy. Methods: Both diagnosis and treatment were divided into three groups voluntarily. l. diagnosis - dermatic symptoms, mucosal symptoms, general symptoms 2. treatment - herbal medications, moxibustion, medicines used extemally(外用藥) Results : After treating 9 months, the condition of the patient grew better and the grades of severity of ROEB-mitis disease were lower at each diagnosis item. Conclusions : As above results, oriental medical treatments were very effective for this disease. But more case studies are necessary for establishing more effective diagnosis and treatment methods.

  • PDF

한우에서 생식기질환의 치료 및 조기임신진단을 위한 초음파영상진단 (Ultrasonographic Diagnosis for the Treatment of Genital Disease and Early Pregnancy Diagnosis in Korean Native Cattle)

  • 황광남;김명철;변홍섭;박명호;이경광;한용만;신상태
    • 한국가축번식학회지
    • /
    • 제21권1호
    • /
    • pp.31-37
    • /
    • 1997
  • Ultrasonographic diagnosis of genital disease and early pregnancy diagnosis was performed in Korean native cattle. The size of ovarian follicle in preovulation, luteal stage and follicular cyst was 18.9, 9.2 and 27.6 mm, respectively, and the thickness of follicular wall was 2.3, 1.8 and 2.8 mm, respectively. The size of corpus luteums in formation stage, activity stage, regression stage, cystic corpora lutea and luteal cyst was 6.2, 11.3, 8.6, 26.7 and 25.9 mm, respectively. The thickness of luteal wall in cystic corpora lutea and luteal cyst was 8.4 and 4.9 mm, respectively. The size of embryo or fetus on day 25, 27, 30, 35, 40, 45 and 50 was 0.8, 0.9, 1.3, 1.5, 2.2, 2.8 and 3.8 cm, respectively. The size of amniotic vesicle on day 25, 27 and 30 was 1.2, 2.1 and 3,0 cm, respectively. The diameter of pregnant uterus on day 25 and 27 was 7.0 and 7.8 cm, respectively. It was concluded that the ultrasonographci values determined in this study can be used as references for the treatment of genital disease and early pregnancy diagnosis in Korean native cattle.

  • PDF

알쯔하이머병(Alzheimer's disease)에서 FDG PET의 임상이용 (Clinical Application of $^{18}F-FDG$ PET in Alzheimer's Disease)

  • 유영훈
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권sup1호
    • /
    • pp.166-171
    • /
    • 2008
  • PET of the cerebral metabolic rate of glucose is increasingly used to support the clinical diagnosis in the examination of patients with suspected major neurodegenerative disorders, such as Alzheimer's disease. $^{18}F-FDG$ PET has been reported to have high diagnostic performance, especially, very high sensitivity in the diagnosis and clinical assessment of therapeutic efficacy. According to clinical research data hitherto, $^{18}F-FDG$ PET is expected to be an effective diagnostic tool in early and differential diagnosis of Alzheimer's disease. Since 2004, Medicare covers $^{18}F-FDG$ PET scans for the differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer's disease (AD) under specific requirements; or, its use in a CMS approved practical clinical trial focused on the utility of $^{18}F-FDG$ PET in the diagnosis or treatment of dementing neurodegenerative diseases.

진단나이 및 치료시점 코호트를 활용한 2010~2017년 고혈압 질환 손실비 추계 (Estimation of the Cost of Hypertension Disease Loss in 2010-2017 Using Cohort at Diagnosis Age and Treatment Time)

  • 노윤곤;이상호;최경식;송태민
    • 한국콘텐츠학회논문지
    • /
    • 제22권2호
    • /
    • pp.782-793
    • /
    • 2022
  • 만성질환의 증가는 국민의 삶에 부정적인 영향을 미칠 뿐 아니라, 보건의료 기술의 향상, 평균 수명 증가, 급속한 인구고령화 등에 따른 의료이용으로 의료비 재정에 대한 부담을 가중시킨다. 이에 본 연구는 만성질환 중 대표질환인 고혈압을 중심으로 인구통계학적 정보에 따른 질환손실비의 차이 및 초기 진단 나이와 치료기간이 질환손실비에 주는 영향을 살펴보았다. 이를 위해 2010년부터 2017년까지의 한국의료패널조사를 이용하였으며, 30세에서 80세 미만의 건강보험적용대상자를 기준으로 대상자를 선정하였다. 선정된 데이터로 질병비용접근법에 따라 질환손실비의 직접비용과 간접비용을 계산했으며, 고혈압에 대한 진단 나이와 치료 시점을 고려해 질환손실비 코호트를 구축하였다. 연구 결과에 따르면 고혈압 환자의 연간 질환손실비는 성별에 따라 110,107원의 차이가 있었고, 치료 시점이 증가할수록 1.8배가량 비용이 증가하는 것으로 나타났다. 또한 같은 나이대 간 질환손실비 비교에서 60대와 70대의 질환손실비는 치료 시점 변수에 영향을 받는 것으로 나타났다. 본 연구를 통해 고혈압이 질병 비용에 큰 영향을 미치고 조기 진단 관리가 필요할 뿐만 아니라, 고혈압 질환의 발병률을 낮추기 위한 예방적 노력을 강화해야 한다는 점이 확인되었다.

Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis

  • Yejin Ahn;Jong Hoon Park
    • Biomolecules & Therapeutics
    • /
    • 제32권3호
    • /
    • pp.291-300
    • /
    • 2024
  • Autosomal dominant polycystic kidney disease (ADPKD), a congenital genetic disorder, is a notable contributor to the prevalence of chronic kidney disease worldwide. Despite the absence of a complete cure, ongoing research aims for early diagnosis and treatment. Although agents such as tolvaptan and mTOR inhibitors have been utilized, their effectiveness in managing the disease during its initial phase has certain limitations. This review aimed to explore new targets for the early diagnosis and treatment of ADPKD, considering ongoing developments. We particularly focus on cell polarity, which is a key factor that influences the process and pace of cyst formation. In addition, we aimed to identify agents or treatments that can prevent or impede the progression of renal fibrosis, ultimately slowing its trajectory toward end-stage renal disease. Recent advances in slowing ADPKD progression have been examined, and potential therapeutic approaches targeting multiple pathways have been introduced. This comprehensive review discusses innovative strategies to address the challenges of ADPKD and provides valuable insights into potential avenues for its prevention and treatment.

인후두 역류 질환: 진단 및 치료 (Laryngopharyngeal Reflux Disease: Diagnosis and Treatment in 2021)

  • 강정욱;은영규
    • 대한후두음성언어의학회지
    • /
    • 제32권2호
    • /
    • pp.56-63
    • /
    • 2021
  • Laryngopharyngeal reflux disease (LPRD) is an inflammatory condition of the upper aerodigestive tract mucosa induced by reflux content from stomach. Some of vocal cord diseases are associated with laryngopharyngeal reflux. Because of the pathophysiological features, proton pump inhibitor shows therapeutic effect on some vocal cord diseases. As like that, the gastric reflux contents can make macroscopic or microscopic morphological changes in the upper aerodigestive tract mucosa. Although the pathophysiology of LPRD is relatively clear, clinical diagnosis is still difficult. The diagnosis of LPRD includes objective tests such as 24-hours multichannel intraluminal impedance-pH metry and subjective tests such as questionnaire method. However, the objective verification of reflux is difficult due to invasiveness of the method, and the questionnaire methods have limitations because many symptoms are not specific for LPRD. Moreover, most methods are not fully standardized until now. Despite these limitations, many researchers are struggling to standardize diagnosis and treatment of LPRD, and there are several new achievements recently. Therefore, the purpose of this article is to review the recent literature on the clinical presentation, diagnosis, and treatment of LPRD, and to systematize our knowledge.

Massive cerebral venous sinus thrombosis secondary to Graves' disease

  • Son, Hye-Min
    • Journal of Yeungnam Medical Science
    • /
    • 제36권3호
    • /
    • pp.273-280
    • /
    • 2019
  • Cerebral venous sinus thrombosis (CVT) is a rare cerebrovascular condition accounting for 0.5-1% of all types of strokes in the general population. Hyperthyroidism is associated with procoagulant and antifibrinolytic activity, thereby precipitating a hypercoagulable state that predisposes to CVT. We report the case of a 31-year-old Korean man with massive CVT and diagnosis of concomitant Graves' disease at admission. Early diagnosis and prompt treatment of CVT are important to improve prognosis; therefore, CVT should be considered in the differential diagnosis in all patients with hyperthyroidism presenting with neurological symptoms.

Evaluation of Appropriate Management of Chronic Obstructive Pulmonary Disease in Korea: Based on Health Insurance Review and Assessment Service (HIRA) Claims

  • Chung, Sang Mi;Lee, Sung Yong
    • Tuberculosis and Respiratory Diseases
    • /
    • 제80권3호
    • /
    • pp.241-246
    • /
    • 2017
  • Chronic obstructive pulmonary disease (COPD) is an ambulatory care-sensitive condition, and effective treatment of outpatients can prevent worsening of the illness and hospitalization. Current COPD guidelines provide appropriate guidance for the diagnosis and treatment of patients with COPD. In fact, it has been shown that when appropriate guidance and treatment are performed, the morbidity and mortality rates of COPD patients are reduced. However, there is a gap between the clinical guidelines and the actual clinical treatment. Therefore, the Health Insurance Review and Assessment Service (HIRA) conducted an evaluation of the adequacy of COPD diagnosis and treatment using the Claims Database of HIRA. This review provides a summary of the COPD adequacy assessment results reported by the HIRA and some brief comments on the results.